NLS Global report

The USA was hit hard by the COVID-19 pandemic. What insights have been made, what actions have been taken, what are the new strategies and how is the country preparing for the next one? The world has suffered immensely over the past three years as leaders have navigated their way through a never-before-seen health crisis. […]

This year’s theme was ‘Stand Up for Science’ but the world’s largest biotechnology conference covers so much more and attracted companies, investors and policy makers from around the globe – including, of course, those representing the Nordics. Although partnering is the main reason why most companies’ management team attend the event, BIO is also the […]

Novartis has entered into an agreement to acquire Chinook Therapeutics, a Seattle, WA, based clinical stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney diseases. The agreed deal, which is subject to customary closing conditions, is fully in line with Novartis strategy to focus on innovative medicines and will […]

This year’s BIO international Convention is back in Boston again after 5 years in other cities or going digital during the pandemic. Considering the number of attendees (at least 18,000 from 85 countries) and exhibiting companies in a fully packed exhibition area, it feels like BIO in Boston 2018, yet significantly different in some respects. […]

Pfizer and Seagen have entered into a definitive merger agreement under which Pfizer will acquire Seagen for 229 USD in cash per Seagen share for a total enterprise value of 43 billion USD. “Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the […]

The partners in Pandemic Antiviral Discovery (PAD) initiative has announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans. These grants mark the majority of the first investments to come from the PAD initiative, a global philanthropic collaboration […]